Use of vaccine trials to estimate burden of disease

Journal of Health, Population and Nutrition

Volumn 22, Issue 3, 2004, Pages 257-267

  Mulholland, E Kim ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Disease burden; Morbidity; Vaccines

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; CHOLERA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; LIVE VACCINE; MEASLES VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ARTICLE; BACTERIAL MENINGITIS; CHILD; CHOLERA; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; ERROR; HEALTH CARE FINANCING; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; MEASLES; NEWBORN MORTALITY; NEWBORN TETANUS; NONHUMAN; RESPIRATORY TRACT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS; VACCINATION;

CLINICAL TRIALS; COST OF ILLNESS; DEVELOPING COUNTRIES; DYSENTERY; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; PNEUMONIA;

HAEMOPHILUS; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 9744222651     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Plotkin SL, Plotkin SA. A short history of vaccination. In Plotkin SA, Orenstein WA, editors. Vaccines. 3d ed. Philadelphia: Saunders, 1999:1-12.
2. Batson A, Glass S, Seiguer E. Economics of vaccines: from vaccine candidate to a commercialized product. In: Bloom BR, Lambert P-H, editors. The vaccine book. San Diego: Academic Press, 2003:345-70.
3. Chippaux JP, Debois H, Saliou P. A critical review of control strategies against meningococcal meningitis epidemics in sub-Saharan African countries. Infection 2002;30:216-24.
4. Rodrigues LC. Smith PG. Use of the case-control approach in vaccine evaluation: efficacy and adverse effects. Epidemiol Rev 1999;21:56-72.
5. Greenwood M, Jr., Yule GU. The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general. Proc R Soc Med 1915;8:113.
6. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N (Vaccine Trialists Group). A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8.
7. Lankinen KS, Ruutu P, Nohynek H, Lucero M, Paton JC, Leinonen M. Pneumococcal pneumonia diagnosis by demonstration of pneumolysin antibodies in precipitated immune complexes: a study in 350 Philippine children with acute lower respiratory infection. Scand J Infect Dis 1999;31:155-61.
8. Nicholas DD, Kratzer JH, Ofosu-Amaah S, Belcher DW. Outside Europe. Is poliomyelitis a serious problem in developing countries? - the Danfa experience. Br Med J 1977;1:1009-12.
9. Forgie IM, Campbell H, Lloyd-Evans N, Leinonen M, O'Neill KP, Saikku P et al. Etiology of acute lower respiratory infections in children in a rural community in the Gambia. Pediatr Infect Dis 1992;11:466-73.
10. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
11. Scott JAG, Hall AJ, Dagan R, Dixon JMS, Eykyn SJ, Fenoll A et al. Serogroup-specific epidemiology of Streptococcus pneumoniae associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 1996;22:973-81.
12. Velazquez FR, Matson DO, Calva JJ, Guerrero ML, Morrow AL, Carter-Campbell S et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996;335: 1022-8.
13. Shinefield HR, Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 2000;19:394-7.
14. Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiol Rev 1999;21:43-55.
15. White NJ, Miller KD, Marsh K, Berry CD, Turner RC, Williamson DH et al. Hypoglycaemia in African children with severe malaria. Lancet 1987;1:708-11.
16. Stanfield JP, Galazka A. Neonatal tetanus in the world today. Bull World Health Organ 1984;62: 647-69.
17. Rahman M, Chen LC, Chakraborty J, Yunus M, Chowdhury AI, Sarder AM et al. Use of tetanus toxoid for the prevention of neonatal tetanus. I: Reduction of neonatal mortality by immunization of pregnant and non-pregnant women in rural Bangladesh. Bull World Health Organ 1982;60: 261-7.
18. Black RE, Huber DH, Curlin GT. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ 1980; 58:927-30.
19. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
20. Bijlmer HA. Epidemiology of Haemophilus influenzae invasive disease in developing countries and intervention strategies. In: Ellis RW, Granoff DM, editors. Development and uses of Haemophilus b conjugate vaccines. New York: Marcel Dekker, 1994:247-64.
21. Greenwood BM. Epidemiology of acute lower respiratory tract infections, especially those due to Haemophilus influenzae type b, in the Gambia, West Africa. J Infect Dis 1992;165(Suppl 1):S26-8.
22. Salisbury DM. Summary statement: the first international conference on Haemophilus influenzae type b infection in Asia. Pediatr Infect Dis J 1998;17:S93-5.
23. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349: 1191-7.
24. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRPT conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996; 15:216-22.
25. Levine OS, Lagos R, Muñoz A, Villaroel J, Alvarez AM, Abrego P et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999;18:1060-4.
26. Gessner BD for the Lombok Hib Study Group. A randomized, controlled clinical trial of the effect of Haemophilus influenzae type b (Hib) vaccine on pneumnonia and meningitis in children living on Lombok Island Indonesia (abstract). In: Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 14-17 September 2003. Washington, DC: American Society for Microbiology, 2003:G-2054a. (http://www.icaac.org/43ICAAC/latbre_new.asp, accessed on 30 August 2004).
27. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-8.
28. Butler JRG, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B. The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 2004;22:1138-49.
29. Falade AG, Mulholland EK, Adegbola RA, Greenwood BM. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop Paediatr 1997; 17:315-9.
30. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995;33:2759-62.
31. Spratt BG, Greenwood BM. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 2000;356:1210-1.
32. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R et al. (Active Bacterial Core Surveillance of the Emerging Infections Program Network). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.
33. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. Br Med J 2000;321: 1435-9.
34. World Health Organization. Nonspecific effects of childhood immunization. Wkly Epidemiol Rec 2004;79:17.
35. Welsh RM, Selin LK. No one is naïve: the significance of heterologous T-cell immunity. Nature Rev Immunol 2002;2:417-26.